CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice
2022-12-01
发表期刊INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
EISSN1422-0067
卷号23期号:24
发表状态已发表
DOI10.3390/ijms232415931
摘要Non-alcoholic fatty liver disease (NAFLD) is a chronic metabolic disease manifested in hepatic steatosis, inflammation, fibrosis, etc., which affects over one-quarter of the population around the world. Since no effective therapeutic drugs are available to cope with this widespread epidemic, the functional research of genes with altered expression during NAFLD helps understand the pathogenesis of this disease and the development of new potential therapeutic targets for drugs. In the current work, we discovered via the analysis of the Gene Expression Omnibus (GEO) dataset that cysteine sulfinic acid decarboxylase (CSAD) decreased significantly in NAFLD patients, which was also confirmed in multiple NAFLD mouse models (HFD-fed C57BL/6J, db/db and HFHFrHC-fed C57BL/6J mice). Next, CSAD's function in the progression of NAFLD was explored using AAV-mediated liver-directed gene overexpression in an HFD-fed mouse model, where the overexpression of CSAD in the liver could alleviate NAFLD-associated pathologies, including body weight, liver/body weight ratio, hepatic triglyceride and total cholesterol, and the degree of steatosis. Mechanically, we found that the overexpression of CSAD could increase the expression of some genes related to fatty acid beta-oxidation (Acad1, Ppara, and Acox1). Furthermore, we also detected that CSAD could improve mitochondrial injury in vitro and in vivo. Finally, we proposed that the effect of CSAD on lipid accumulation might be independent of the taurine pathway. In conclusion, we demonstrated that CSAD is involved in the development of NAFLD as a protective factor, which suggested that CSAD has the potential to become a new target for drug discovery in NAFLD.
关键词NAFLD CSAD obesity liver damage fatty acid beta-oxidation mitochondrial damage
URL查看原文
收录类别SCI
语种英语
资助项目[ZYYCXTD-D-202210] ; [21DZ2291100]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry
WOS类目Biochemistry & Molecular Biology ; Chemistry, Multidisciplinary
WOS记录号WOS:000901246100001
出版者MDPI
引用统计
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/268690
专题生命科学与技术学院_博士生
生命科学与技术学院_特聘教授组_任进组
通讯作者Zhang, Xuemei; Ren, Jin
作者单位
1.Fudan Univ, Sch Pharm, Dept Pharmacol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Safety Evaluat & Res, State Key Lab Drug Res, 501 Haike Rd, Shanghai 201203, Peoples R China
3.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China
4.Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China
通讯作者单位生命科学与技术学院
推荐引用方式
GB/T 7714
Tan, Rongrong,Li, Jiayang,Liu, Lu,et al. CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2022,23(24).
APA Tan, Rongrong.,Li, Jiayang.,Liu, Lu.,Wu, Qian.,Fan, Lei.,...&Ren, Jin.(2022).CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,23(24).
MLA Tan, Rongrong,et al."CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice".INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 23.24(2022).
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Tan, Rongrong]的文章
[Li, Jiayang]的文章
[Liu, Lu]的文章
百度学术
百度学术中相似的文章
[Tan, Rongrong]的文章
[Li, Jiayang]的文章
[Liu, Lu]的文章
必应学术
必应学术中相似的文章
[Tan, Rongrong]的文章
[Li, Jiayang]的文章
[Liu, Lu]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 10.3390@ijms232415931.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。